Applied therapeutics to present at the 14th international congress of inborn errors of metabolism

New york, nov. 18, 2021 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, has announced a symposium and poster presentations at the 14th international congress of inborn errors of metabolism (iciem), november 21-23, 2021, sydney, australia.
APLT Ratings Summary
APLT Quant Ranking